AWAK Technologies, a Singapore-based medical technology company, has raised USD40 million in a financing round led by Vickers Venture Partners, a global venture capital firm. Additional investors include SEEDS Capital, the Southeast Asia-focused investment arm of Enterprise Singapore, and Advanced MedTech, a Singapore-based medical technology company. AWAK develops treatment devices for end-stage kidney disease. The company intends to use the fresh capital to test and market its AWAK Peritoneal Dialysis device.